Powerful chemical patents with Markush Editor DX!

We have started handling "PatSnap," which is innovating patent research with advanced AI, from this spring. We will be exhibiting at the Pharma IT & Digital Health Expo, so please come and visit us. PatSnap is a rapidly growing venture company from Singapore, offering cutting-edge user interfaces and AI technology at reasonable prices. It is an AI venture with significant potential, attracting investments from companies like SoftBank and Vertex. Exhibited Products: Synapse: Assists in identifying a more comprehensive pipeline, potential risks, white spaces, and partnership opportunities using AI. Eureka: A uniquely developed, secure patent-focused GPT for idea validation, summarization, claim drafting, Q&A, etc. (World's first). Bio: One of the world's largest patent research databases for nucleic acid and amino acid sequences. Ensures more reliable biological sequence FTO with state-of-the-art degenerate sequence searching. Chemical: Searches for patents, clinical trials, and approval data from the FDA, Ministry of Health, Labour and Welfare, NMPA, etc., based on chemical structures, substance names, and CAS numbers. Analytics: Easily searches highly relevant patent information with an intuitive GUI. Provides AI tools for analysis.

In the webinar, we will introduce how the Markush Editor is revolutionizing the creation of patent claims through a video lasting approximately 35 minutes. Markush claims are typically complex and labor-intensive, but by using the Markush Editor, digital transformation (DX) becomes possible, reducing a task that used to take two weeks to just two days. Please join us in this webinar to see its effects. 【Overview】 - Introduction to the Markush Editor - Presentation of specific operational images through a demo - Automatic creation of Markush structures from example structural groups - Inclusion check of example structures against Markush structures - Adjustment of Markush structures - Automatic generation of Markush claim drafts 【How to Watch】 Click on "Markush Editor On-Demand Webinar" in the "Related Links" below, download the PDF, and click the link button in the PDF to watch the webinar.

Chemaxon, a leader in the development of cheminformatics software for life sciences research, has announced the appointment of Richard Jones as Chief Executive Officer (CEO). Richard succeeds the owner, Ferenc (Csizi) Csizmadia, in this role. Csizi will continue to serve as a founder while focusing on the establishment of Ancestralize, which is centered on health and wellness in the digital age. Additionally, coinciding with Mr. Richard's appointment, Chemaxon's Budapest office has relocated to the newly constructed environmentally friendly office park, Váci Greens, on the east side of the Danube River. A new logo and spelling have also been announced. For more details, please visit the news article on our company's homepage via the link below.